Glazer Capital »

Peregrine Pharmaceuticals shares owned by Glazer Capital

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Glazer Capital from 13F filings

Historical chart of Glazer Capital investment in Peregrine Pharmaceuticals

23:59:59.999Dec 30, 202423:59:59.999500:00:00Dec 31, 202400:00:00.000500:00:00.00145.907047M45.9070475M45.907048M45.9070485M45.907049M3.717199M3.7171995M3.7172M3.7172005M3.717201M
Value ($)Share countHistorical CDMO position of Glazer Capital Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Glazer Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Glazer Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $46M 3.7M 12.35

More positions owned by Glazer Capital

Smartsheet Com Cl A (SMAR)
Enstar Group SHS (ESGR)
Infinera
Zuora Com Cl A
Barnes (B)
Air Transport Services (ATSG)
Fluor Corp Note 1.125% 08/01/2029 (Principal)
Peregrine Pharmaceuticals (CDMO)
Revelyst SHS
Everi Hldgs (EVRI)
Patterson Companies (PDCO)
Retail Opportunity Investments
Nordstrom (JWN)
Gatos Silver (GATO)
Livent Corp Note 4.125% 07/01/2025 (Principal)

View all positions for Glazer Capital

Top funds holding Peregrine Pharmaceuticals

BlackRock
AltraVue Capital
Vanguard Group
Glazer Capital
Punch & Associates Investment Management
State Street Corporation
Fil
Royal Bank of Canada
Goldman Sachs Group
Alpine Associates Management
Highland Capital Management Fund Advisors
Water Island Capital
CNH Partners
Hsbc Holdings
Geode Capital Management

View all funds holding Peregrine Pharmaceuticals